ODDO BHF SECURITIES LARGE CAPS MORNING NEWS 02/27/2026

ODDO BHF SECURITIES LARGE CAPS MORNING NEWS 27/02/2026

ACERINOX: FY2025 RESULTS AND T.P. INCREASE (ANÁLISIS BANCO SABADELL)

4Q'25 vs. 4Q'24 Results Sales: € 1.31 Bn (-1.3% vs. -24.1% BS(e) and -18.8% consensus); EBITDA: € 32 M (-78.7% vs. +116.6% BS(e) and +80.2% consensus); EBIT: € -23 M (116 M in 4Q'24 vs. 10 M BS(e) and 17 M consensus); Net Profit: € -47 M (€ 63 M in 4Q’24 vs. -15 M BS(e) and 17 M consensus); 2025 vs. 2024 Results Sales: € 5.78 Bn (+6.8% vs. +8.4% BS(e) and +6.2% consensus); EBITDA: € 354 M (-29.2% vs. -23.6% BS(e) and -20.0% consensus); EBIT: € 153 M (-56.0% vs. -46.6% BS(e) and -44.5% consensus); Net Profit: € -40 M (225 M in 2024 vs. -8 M BS(e) and 24 M consensus).

VISCOFAN: 4Q’25 RESULTS (ANÁLISIS BANCO SABADELL)

4Q'25 vs. 4Q'24 Results Sales: € 315.12 M (+3.1% vs. +0.1% BS(e) and +2.2% consensus); EBITDA: € 71.75 M (-9.1% vs. +0.7% BS(e) and -2.3% consensus). FY2025 vs. FY2024 Results Sales: € 1.252 Bn (+4.0% vs. +3.2% BS(e) and +3.8% consensus); EBITDA: € 289.99 M (+1.6% vs. +4.3% BS(e) and +3.5% consensus).

CELLNEX: FY2025 RESULTS (ANÁLISIS BANCO SABADELL)

4Q'25 vs. 4Q'24 Results Sales: € 1.058 Bn (+1.9% vs. -1.4% BS(e) and +1.0% consensus); EBITDA: € 881.0 M (+2.1% vs. +0.1% BS(e) and +1.0% consensus); FY2025 vs. FY2024 Results Sales: € 3.995 Bn (+1.4% vs. +0.5% BS(e) and +1.1% consensus); EBITDA: € 3.317 Bn (+2.1% vs. +1.5% BS(e) and +1.8% consensus); Net Profit: € -361.0 M (€ -28.0 M in FY2024);